These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 36373776

  • 1. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
    Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AK, Cheung AH, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Xiao J, Wong CC, Wu WK, Cheng AS, Ma BB, Yu J, Lo KW, Kang W, Ka Fai ToDepartment of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, PR China.Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, PR China.State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, PR China..
    J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
    [Abstract] [Full Text] [Related]

  • 2. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
    Unger C, Kramer N, Unterleuthner D, Scherzer M, Burian A, Rudisch A, Stadler M, Schlederer M, Lenhardt D, Riedl A, Walter S, Wernitznig A, Kenner L, Hengstschläger M, Schüler J, Sommergruber W, Dolznig H.
    Oncogene; 2017 Sep 21; 36(38):5341-5355. PubMed ID: 28534511
    [Abstract] [Full Text] [Related]

  • 3. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
    Kobayashi H, Gieniec KA, Lannagan TRM, Wang T, Asai N, Mizutani Y, Iida T, Ando R, Thomas EM, Sakai A, Suzuki N, Ichinose M, Wright JA, Vrbanac L, Ng JQ, Goyne J, Radford G, Lawrence MJ, Sammour T, Hayakawa Y, Klebe S, Shin AE, Asfaha S, Bettington ML, Rieder F, Arpaia N, Danino T, Butler LM, Burt AD, Leedham SJ, Rustgi AK, Mukherjee S, Takahashi M, Wang TC, Enomoto A, Woods SL, Worthley DL.
    Gastroenterology; 2022 Mar 21; 162(3):890-906. PubMed ID: 34883119
    [Abstract] [Full Text] [Related]

  • 4. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
    Vaquero J, Lobe C, Tahraoui S, Clapéron A, Mergey M, Merabtene F, Wendum D, Coulouarn C, Housset C, Desbois-Mouthon C, Praz F, Fouassier L.
    Clin Cancer Res; 2018 Sep 01; 24(17):4282-4296. PubMed ID: 29716918
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T, Wang J, Liu P, Chi J, Yan H, Lei L, Li Z, Yang B, Wang X.
    Oncotarget; 2017 Jul 18; 8(29):47269-47283. PubMed ID: 28521298
    [Abstract] [Full Text] [Related]

  • 6. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
    Deng S, Cheng D, Wang J, Gu J, Xue Y, Jiang Z, Qin L, Mao F, Cao Y, Cai K.
    J Exp Clin Cancer Res; 2023 Nov 06; 42(1):294. PubMed ID: 37926835
    [Abstract] [Full Text] [Related]

  • 7. Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal Cancers.
    Chen CY, Yang SH, Chang PY, Chen SF, Nieh S, Huang WY, Lin YC, Lee OK.
    Cells; 2024 Aug 12; 13(16):. PubMed ID: 39195225
    [Abstract] [Full Text] [Related]

  • 8. PA28γ coordinates the cross-talk between cancer-associated fibroblasts and tumor cells to promote OSCC progression via HDAC1/E2F3/IGF2 signaling.
    Li Z, Sun S, Wang Y, Hua Y, Liu M, Zhou Y, Zhong L, Li T, Zhao H, Zhou X, Zeng X, Chen Q, Li J.
    Cancer Lett; 2024 Jul 10; 594():216962. PubMed ID: 38768680
    [Abstract] [Full Text] [Related]

  • 9. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A, Adamek A.
    Int J Mol Sci; 2019 Oct 03; 20(19):. PubMed ID: 31623387
    [Abstract] [Full Text] [Related]

  • 10. YAP, a novel target regulates F-actin rearrangement-associated CAFs transformation and promotes colorectal cancer cell progression.
    Naktubtim C, Payuhakrit W, Uttarawichien T, Hassametto A, Suwannalert P.
    Biomed Pharmacother; 2022 Nov 03; 155():113757. PubMed ID: 36271545
    [Abstract] [Full Text] [Related]

  • 11. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
    Zhang J, Wong CC, Leung KT, Wu F, Zhou Y, Tong JHM, Chan RCK, Li H, Wang Y, Yan H, Liu L, Wu WKK, Chan MWY, Cheng ASL, Yu J, Wong N, Lo KW, To KF, Kang W.
    Oncogene; 2020 Oct 03; 39(43):6647-6663. PubMed ID: 32934314
    [Abstract] [Full Text] [Related]

  • 12. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
    Aizawa T, Karasawa H, Funayama R, Shirota M, Suzuki T, Maeda S, Suzuki H, Yamamura A, Naitoh T, Nakayama K, Unno M.
    Cancer Med; 2019 Oct 03; 8(14):6370-6382. PubMed ID: 31468733
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
    Wang L, Yang D, Tian J, Gao A, Shen Y, Ren X, Li X, Jiang G, Dong T.
    Oncotarget; 2017 Apr 18; 8(16):26323-26333. PubMed ID: 28412748
    [Abstract] [Full Text] [Related]

  • 14. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
    Cacheux W, Lièvre A, Richon S, Vacher S, El Alam E, Briaux A, El Botty R, Mariani P, Buecher B, Schnitzler A, Barbazan J, Roman-Roman S, Bièche I, Dangles-Marie V.
    Int J Cancer; 2019 Oct 01; 145(7):1852-1859. PubMed ID: 30714617
    [Abstract] [Full Text] [Related]

  • 15. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC, Graham LD, Molloy PL.
    Biochim Biophys Acta; 2014 Feb 01; 1843(2):372-86. PubMed ID: 24184209
    [Abstract] [Full Text] [Related]

  • 16. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
    Lu C, Zhang C.
    Clin Transl Oncol; 2023 Jan 01; 25(1):160-172. PubMed ID: 36129606
    [Abstract] [Full Text] [Related]

  • 17. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
    Li Z, Pan W, Shen Y, Chen Z, Zhang L, Zhang Y, Luo Q, Ying X.
    Cell Cycle; 2018 Jan 01; 17(10):1212-1219. PubMed ID: 29886785
    [Abstract] [Full Text] [Related]

  • 18. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y, Tong JHM, Lung RWM, Kang W, Kwan JSH, Chak WP, Tin KY, Chung LY, Wu F, Ng SSM, Mak TWC, Yu J, Lo KW, Chan AWH, To KF.
    Mol Cancer; 2018 Jul 23; 17(1):102. PubMed ID: 30037330
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.
    Lin F, Shen Z, Xu X, Hu BB, Meerani S, Tang LN, Zheng SE, Sun YJ, Min DL, Yao Y.
    Int J Immunopathol Pharmacol; 2013 Jul 23; 26(1):169-77. PubMed ID: 23527719
    [Abstract] [Full Text] [Related]

  • 20. IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy.
    Gao T, Liu X, He B, Pan Y, Wang S.
    Aging (Albany NY); 2020 Nov 05; 12(21):21236-21252. PubMed ID: 33173015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.